Agios Pharmaceuticals, Inc.
AGIO
$29.20
-$1.03-3.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 854.43M | 952.86M | 938.94M | 893.38M | 893.71M |
| Total Receivables | 10.78M | 5.03M | 4.99M | 3.34M | 4.11M |
| Inventory | 32.92M | 32.03M | 30.85M | 29.61M | 27.62M |
| Prepaid Expenses | 43.93M | 43.19M | 44.69M | 42.29M | 40.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 942.05M | 1.03B | 1.02B | 968.62M | 965.60M |
|
|
|||||
| Total Current Assets | 942.05M | 1.03B | 1.02B | 968.62M | 965.60M |
| Net Property, Plant & Equipment | 41.23M | 44.33M | 47.36M | 50.93M | 54.55M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.93M | 3.93M | 3.94M | 4.72M | 4.72M |
| Total Assets | 1.30B | 1.39B | 1.47B | 1.56B | 1.66B |
|
|
|||||
| Total Accounts Payable | 18.36M | 19.55M | 17.53M | 13.73M | 16.64M |
| Total Accrued Expenses | 45.46M | 37.22M | 35.29M | 20.76M | 46.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.39M | 17.99M | 17.59M | 17.20M | 16.78M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 683.00K | 871.00K |
| Total Other Current Liabilities | -- | -- | -- | 683.00K | 871.00K |
| Total Current Liabilities | 82.21M | 74.76M | 70.41M | 52.37M | 81.16M |
|
|
|||||
| Total Current Liabilities | 82.21M | 74.76M | 70.41M | 52.37M | 81.16M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 21.82M | 26.53M | 31.17M | 35.74M | 40.21M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 90.00K | 90.00K | 101.00K | 880.00K | 880.00K |
| Total Liabilities | 104.11M | 101.38M | 101.68M | 88.99M | 122.24M |
|
|
|||||
| Common Stock & APIC | 2.56B | 2.54B | 2.52B | 2.51B | 2.49B |
| Retained Earnings | -561.71M | -453.67M | -350.23M | -238.21M | -148.92M |
| Treasury Stock & Other | -800.29M | -800.44M | -801.83M | -802.12M | -804.00M |
| Total Common Equity | 1.19B | 1.28B | 1.37B | 1.47B | 1.54B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.19B | 1.28B | 1.37B | 1.47B | 1.54B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.19B | 1.28B | 1.37B | 1.47B | 1.54B |
|
|
|||||